Tumor hypoxia does not drive differentiation of tumor-associated macrophages but rather fine-tunes the M2-like macrophage population

Cancer Research

Volumn 74, Issue 1, 2014, Pages 24-30

  Laoui, Damya ^a   Van Overmeire, Eva ^a   Conza, Giusy Di ^a   Aldeni, Chiara ^a   Keirsse, Jiri ^a   Morias, Yannick ^a   Movahedi, Kiavash ^a   Houbracken, Isabelle ^b   Schouppe, Elio ^a   Elkrim, Yvon ^a   Karroum, Oussama ^a   Jordan, Bénédicte ^a   Carmeliet, Peter ^a   Gysemans, Conny ^a   DeBaetselier, Patrick ^a   Mazzone, Massimiliano ^a   Van Ginderachter, Jo A ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CANCER CELL; CELL DIFFERENTIATION; CELL INFILTRATION; CELL POPULATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HYPOXIA; IN VIVO STUDY; LUNG CARCINOMA; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; TUMOR ASSOCIATED LEUKOCYTE; TUMOR HYPOXIA;

ANIMALS; CELL DIFFERENTIATION; CELL HYPOXIA; DISEASE MODELS, ANIMAL; FEMALE; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASMS; TRANSCRIPTOME;

EID: 84892747845     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-1196     Document Type: Article

References (20)

1. Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 2010;141:39-51.
2. Laoui D, Van Overmeire E, Movahedi K, Van den Bossche J, Schouppe E, Mommer C, et al. Mononuclear phagocyte heterogeneity in cancer: different subsets and activation states reaching out at the tumor site. Immunobiology 2011;216:1192-202.
3. Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006;66:605-12.
4. Movahedi K, Laoui D, Gysemans C, Baeten M, Stange G, Van den Bossche J, et al. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res 2010;70:572839.
5. Wyckoff JB, Wang Y, Lin EY, Li J, Goswami S, Stanley ER, et al. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res 2007;67:2649-56.
6. Muthana M, Giannoudis A, Scott SD, Fang H, Coffelt SB, Morrow FJ, et al. Use of macrophages to target therapeutic adenovirus to human prostate tumors. Cancer Res 2011;71:1805-15
7. Movahedi K, Schoonooghe S, Laoui D, Houbracken I, Waelput W, Breckpot K, et al. Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophages. Cancer Res 2012;72:4165-4177.
8. Osinsky S, Bubnovskaya L, Ganusevich I, Kovelskaya A, Gumenyuk L, Olijnichenko G, et al. Hypoxia, tumour-associated macrophages, microvessel density, VEGF and matrix metalloproteinases in human gastric cancer: interaction and impact on survival. Clin Transl Oncol 2011;13:133-38.
9. Burke B, Giannoudis A, Corke KP, Gill D, Wells M, Ziegler-Heitbrock L, et al. Hypoxia-induced gene expression in human macrophages, implications for ischemic tissue and hypoxia-regulated gene therapy. Am J Pathol. 2003;163:1233-43.
10. Cramer T, Yamanishi Y, Clausen BE, Förster I, Pawlinski R, Mackman N, et al. HIF-1a is essential for myeloid cell-mediated inflammation. Cell 2003;112:645-57.
11. Fang H, Hughes R, Murdoch C, Coffelt C, Biswas SK, Harris AL, et al. Hypoxia inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia. Blood 2009;144: 844-59.
12. Hamilton JA, Lacey DC, Turner A, de Kok B, Huynh J, Scholz GM. Hypoxia enhances the proliferative response of macrophages to CSF-1 and their pro-survival response to TNF. PLoS One 2012;7:e45853.
13. Mazzone M, Dettori D, Leite de Oliveira R, Loges S, Schmidt T, Jonckx B, et al. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 2009;136: 839-51
14. Takeda Y, Costa S, Delamarre E, Roncal C, Leite de Oliveira R, Squadrito ML, et al. Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis. Nature 2011;479: 122-6.
15. Ruffell B, Affara NI, Coussens LM. Differential macrophage programming in the tumor microenvironment. Trends Immunol 2012;33: 119-26.
16. Schouppe E, De Baetselier P, Van Ginderachter JA, Sarukhan A. Instruction of myeloid cells by the tumor microenvironment: open questions on the dynamics and plasticity of different tumor-associated myeloid cell populations. OncoImmunol 2012;1:1135-45
17. Mazzieri R, Pucci F, Moi D, Zonari E, Ranghetti A, et al. Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells. Cancer Cell 2011;19:512-26.
18. Doedens AL, Stockmann C, Rubinstein MP, Liao D, Zhang N, DeNardo DG, et al. Macrophage expression of hypoxia-inducible factor-1α suppresses T-cell function and promotes tumor progression. Cancer Res 2010;70:7465-75.
19. Imtiyaz HZ, Williams EP, Hickey MM, Patel SA, Durham AC, Yuan LJ, et al. Hypoxia-inducible factor 2α regulates macrophage function in mouse models of acute and tumor inflammation. J Clin Invest 2010;120:2699-14.
20. Takeda N, O'Dea EL, Doedens A, Kim JW, Weidemann A, Stockmann C, et al. Differential activation and antagonistic function of HIF-α isoforms in macrophages are essential for NO homeostasis. Genes Dev 2011;24:491-501.